Clinical Trials Directory

Trials / Conditions / Prostate Cancer Metastatic Disease

Prostate Cancer Metastatic Disease

18 registered clinical trials studyying Prostate Cancer Metastatic Disease — 13 currently recruiting.

StatusTrialSponsorPhase
RecruitingUsing FAPI PET/MRI to Evaluate Prostate Cancer
NCT06675357
University of Wisconsin, MadisonPhase 2
Not Yet RecruitingLab Research Using Mini-tumors to Study Prostate Cancer Treatments
NCT07004582
Maastricht Radiation Oncology—
Not Yet RecruitingHIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bon
NCT06978296
Institut Cancerologie de l'OuestN/A
RecruitingProof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Me
NCT06957691
Shehzad Basaria, M.D.Phase 2
RecruitingPSMA PET for Surveillance After Focal Therapy
NCT07115914
University of ChicagoN/A
Not Yet RecruitingEfficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer
NCT06718647
Monica Boitano—
RecruitingExploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Ev
NCT06832774
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 2
CompletedA Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer
NCT06840535
Philogen S.p.A.Phase 1
RecruitingPhase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
NCT06849544
Clinton BahlerPhase 2
RecruitingA Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT06800313
Halda Therapeutics OpCo, Inc.Phase 1 / Phase 2
Not Yet RecruitingStudy of HRS-2189 Combined HRS-5041 in Prostate Cancer
NCT06738745
Fudan UniversityPhase 2
RecruitingRadiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
NCT06992232
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 2
CompletedThe Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Ca
NCT06915714
Sun Yat-sen University—
RecruitingRole of Race in Nutritional Approach in Men on ADT
NCT06682390
University of California, Los AngelesN/A
RecruitingProspective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant
NCT06828263
University Hospital, Grenoble—
Completedo Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer
NCT07333976
Tri-Service General HospitalPhase 2
CompletedOsteosclerotic Changes on CT Predict Survival in Prostate Cancer
NCT06883474
Sun Yat-sen University—
TerminatedPhase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
NCT01155791
Sandy SrinivasPhase 1